<DOC>
	<DOCNO>NCT00540527</DOCNO>
	<brief_summary>The purpose study determine whether intra-arterial rt-PA within 6 hour ischemic stroke onset , compare intravenous infusion drug within 3 hour , increase proportion independent survivor 3 month .</brief_summary>
	<brief_title>Local Versus Systemic Thrombolysis Acute Ischemic Stroke ( SYNTHESIS )</brief_title>
	<detailed_description>`` Stroke major cause death severe disability.The effective , available therapy , within hour stroke onset , rt-PA , thrombolytic agent . Preliminary experience properly conduct randomized trial indicate intra-arterial treatment might effective intravenous therapy vascular lesion . Intravenous application test directly intra-arterial treatment know relative clinical effectiveness two route administration . Eligible patient randomize receive either IV rt-PA ( 0.9mg/kg ; max 90 mg ) , 10 % would infuse 1 minute , remainder 60 min , IA rt-PA within thrombus mean microcatheter . In patient allocated IA rt-PA angiogram perform soon possible within 6 hour stroke onset ; IV heparin initiate ( 2000 U bolus follow 500 U7hr infusion ) rt-PA deliver rate 90 mg/hr maximum one hour dose need recanalization 0.9 mg/Kg ( max 90 mg ) . Antithrombotics anticoagulant disallow first 24 hour ( except heparin use angiogram ) . After 24 hr , patient consider long-term antiplatelet anticoagulant therapy . Follow-up take place 7 day , discharge , transfer , whichever first ; 3 month . 4 center currently authorize start-up phase ; 15 center Italy apply expansion phase study ( SYNTHESIS EXPANSION ) , financial support Italian National Agency Drugs ( AIFA ) .The two phase study analyse separately consider pooled analysis .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Inclusion criterion : Sudden focal neurological deficit attributable stroke Clearly define time onset , allow initiation intravenous treatment within 3 hour symptom onset intraarterial treatment within 6 hour symptom onset . Age 18 80 year Exclusion criterion : Disability precede stroke consistent modify Rankin scale score 24 ( see glossary Rankin scale ) Coma onset Severe stroke assess clinically ( e.g . NIHSS &gt; 25 ) Rapidly improve neurological deficit minor symptom Seizure onset stroke Clinical presentation suggestive subarachnoid hemorrhage ( even CT scan normal ) condition subarachnoid hemorrhage aneurysm Previous history suspect intracranial hemorrhage Previous history central nervous system damage ( i.e . neoplasm , aneurysm , intracranial spinal surgery ) Septic embolism , bacterial endocarditis , pericarditis Acute pancreatitis Arterial puncture non compressible site ( e.g . subclavian jugular vein puncture ) traumatic external heart massage obstetrical delivery within previous 10 day Another stroke serious head trauma within precede 3 month Major surgery significant trauma past 3 month Urinary tract hemorrhage within previous 21 day Documented ulcerative gastrointestinal disease last 3 month , esophageal varix , arterialaneurysm , arterial/venous malformation • Neoplasm increase bleed risk Severe liver disease , include hepatic failure , cirrhosis , portal hypertension ( esophageal varix ) active hepatitis Current therapy intravenous subcutaneous heparin oral anticoagulant ( e.g . warfarin sodium ) rise clotting time Known hereditary acquire hemorrhagic diathesis , baseline INR great 1.5 , aPTT 1.5 time normal , baseline platelet count le 100,000 per cubic millimeter Baseline blood glucose concentration 50 mg per deciliter ( 2.75 mm/L ) 400 mg per deciliter Hemorrhagic retinopathy , e.g . diabetes ( vision disturbance may indicate hemorrhagic retinopathy ) Any history prior stroke concomitant diabetes Prior stroke within last 3 month Known contrast sensitivity Severe uncontrolled hypertension define blood pressure ≥ 185 mmHg systolic diastolic ≥ 110 mm Hg 3 separate occasion least 10 minute apart require continuous IV therapy Prognosis poor regardless therapy ; likely dead within month . Unlikely available followup ( e.g. , fix home address , visitor overseas ) .Any condition local investigator feel would pose significant hazard term risk/benefit patient , therapy impracticable . Computed tomographic ( CT ) scan exclusion criterion Intracranial tumor except small meningioma Hemorrhage degree Acute infarction ( since may indicator time onset uncorrected</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>acute ischemic stroke ; thrombolysis ; intraarterial thrombolysis</keyword>
</DOC>